ImmunityBio Inc (NASDAQ: IBRX) is -55.93% lower on its value in year-to-date trading and has touched a low of $1.83 and a high of $7.48 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IBRX stock was last observed hovering at around $2.81 in the last trading session, with the day’s gains setting it 0.09%.
Currently trading at $2.9, the stock is 3.72% and 7.12% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.66 million and changing 3.20% at the moment leaves the stock -11.93% off its SMA200. IBRX registered 13.28% gain for a year compared to 6-month gain of 13.28%. The firm has a 50-day simple moving average (SMA 50) of $2.7072 and a 200-day simple moving average (SMA200) of $3.293.
The stock witnessed a -10.49% loss in the last 1 month and extending the period to 3 months gives it a 17.89%, and is 6.62% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.41% over the week and 6.17% over the month.
ImmunityBio Inc (IBRX) has around 680 employees, a market worth around $2.56B and $31.22M in sales. Profit margin for the company is -1310.30%. Distance from 52-week low is 58.47% and -61.23% from its 52-week high. The company has generated returns on investments over the last 12 months (-182.90%).
The EPS is expected to grow by 23.85% this year.
ImmunityBio Inc (IBRX) Top Institutional Holders
283.0 institutions hold shares in ImmunityBio Inc (IBRX), with institutional investors hold 35.68% of the company’s shares. The shares outstanding are 853.39M, and float is at 91.82M with Short Float at 83.82%. Institutions hold 9.24% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 13.83 million shares valued at $87.42 million. The investor’s holdings represent 2.0135% of the IBRX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.42 million shares valued at $72.19 million to account for 1.6629 of the shares outstanding. The other top investors are STATE STREET CORP which holds 7.86 million shares representing 1.1448% and valued at over $49.7 million, while GEODE CAPITAL MANAGEMENT, LLC holds 0.5703 of the shares totaling 3.92 million with a market value of $24.76 million.
ImmunityBio Inc (IBRX) Insider Activity
#####
